The application of 2D gel-based proteomics methods to the study of breast cancer

Journal of Mammary Gland Biology and Neoplasia

Volumn 7, Issue 4, 2002, Pages 385-393

  Stein, Robert C ^a   Zvelebil, Marketa J ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

2D gel electrophoresis; Bioinformatics; Clustering; Differential protein expression; Proteomics

Indexed keywords

BIOINFORMATICS; BREAST CANCER; BREAST CELL; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRINCIPAL COMPONENT ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; SACCHAROMYCES CEREVISIAE; TWO DIMENSIONAL GEL ELECTROPHORESIS; BIOLOGY; BREAST TUMOR; CLUSTER ANALYSIS; COMPUTER PROGRAM; METABOLISM; METHODOLOGY;

PROTEOME;

BREAST NEOPLASMS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; PROTEOME; SOFTWARE;

EID: 0141559001     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024034031472     Document Type: Review

References (30)

1. M. R. Wilkins, K. L. Williams, R. D. Appel, and D. F. Hochstrasser (1997). Proteome Research: New Frontiers in Functional Genomics, Springer-Verlag, Berlin.
2. P. H. O'Farrell (1975). High resolution two-dimensional electrophoresis of proteins. J Biol. Chem. 250:4007-4021.
3. A. Gorg, C. Obermaier, G. Boguth, A. Harder, B. Scheibe, R. Wildgruber, and W. Weiss (2000). The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21:1037-1053.
4. M. F. Lopez, K. Berggren, E. Chernokalskaya, A. Lazarev, M. Robinson, and W. F. Patton (2000). A comparison of silver stain and SYPRO Ruby Protein Gel Stain with respect to protein detection in two-dimensional gels and identification by peptide mass profiling. Electrophoresis 21:3673-3683.
5. B. Raman, A. Cheung, and M. R. Marten (2002). Quantitative comparison and evaluation of two commercially available, two-dimensional electrophoresis image analysis software packages, Z3 and Melanie. Electrophoresis 23:2194-2202.
6. S. Gharbi, P. Gaffney, A. Yang, M. J. Zvelebil, R. Cramer, M. D. Waterfield, and J. F. Timms (2002). Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol. Cell Proteomics 1:91-98.
7. M. Unlu, M. E. Morgan, and J. S. Minden (1997). Difference gel electrophoresis: A single gel method for detecting changes in protein extracts. Electrophoresis 18:2071-2077.
8. R. Tonge, J. Shaw, B. Middleton, R. Rowlinson, S. Rayner, J. Young, F. Pognan, E. Hawkins, I. Currie, and M. Davison (2001). Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 1:377-396.
9. M. R. Wilkins, E. Gasteiger, J. C. Sanchez, A. Bairoch, and D. F. Hochstrasser (1998). Two-dimensional gel electrophoresis for proteome projects: The effects of protein hydrophobicity and copy number. Electrophoresis 19:1501-1505.
10. S. P. Gygi, G. L. Corthals, Y. Zhang, Y. Rochon, and R. Aebersold (2000). Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc. Natl. Acad. Sci. U.S.A. 97:9390-9395.
11. R. A. VanBogelen, E. E. Schiller, J. D. Thomas, and F. C. Neidhardt (1999). Diagnosis of cellular states of microbial organisms using proteomics. Electrophoresis 20:2149-2159.
12. B. A. Lollo, S. Harvey, J. Liao, A. C. Stevens, R. Wagenknecht, R. Sayen, J. Whaley, and F. G. Sajjadi (1999). Improved two-dimensional gel electrophoresis representation of serum proteins by using ProtoClear. Electrophoresis 20:854-859.
13. C. Gauss, M. Kalkum, M. Lowe, H. Lehrach, and J. Klose (1999). Analysis of the mouse proteome. (I) Brain proteins: separation by two-dimensional electrophoresis and identification by mass spectrometry and genetic variation. Electrophoresis 20:575-600.
14. S. P. Gygi, B. Rist, S. A. Gerber, F. Turecek, M. H. Gelb, and R. Aebersold (1999). Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol 17:994-999.
15. L. Anderson and J. Seilhamer (1997). A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18:533-537.
16. S. P. Gygi, Y. Rochon, B. R. Franza, and R. Aebersold (1999). Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19:1720-1730.
17. R. A. Harris, A. Yang, R. C. Stein, K. Lucy, L. Brusten, A. Herath, R. Parekh, M. D. Waterfield, M. J. O'Hare, M. A. Neville, M. J. Page, and M. J. Zvelebil (2002). Cluster analysis of an extensive human breast cancer cell line protein expression map database. Proteomics 2:212-223.
18. R. D. Zhang, I. J. Fidler, and J. E. Price (1991). Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and brain metastasis. Invasion Metastasis 11:204-215.
19. T. Kohonen (1982). Self-organized formation of topologically correct feature maps. Biol-Cybern. 43:59-69.
20. K. Patel, R. Stein, S. Benvenuti, and M. J. Zvelebil (2002). Combinatorial use of mRNA and two-dimensional electrophoresis expression data to choose relevant features for mass spectrometric identification. Proteomics 2:1464-1473.
21. P. J. Wirth, V. Egilsson, V. Gudnason, S. Ingvarsson, and S. S. Thorgeirsson (1987). Specific polypeptide differences in normal versus malignant human breast tissues by two-dimensional electrophoresis. Breast Cancer Res. Treat 10:177-189.
22. B. Westley and H. Rochefort (1980). A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell 20:353-362.
23. D. K. Trask, V. Band, D. A. Zajchowski, P. Yaswen, T. Suh, and R. Sager (1990). Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 87:2319-2323.
24. A. S. Vercoutter-Edouart, X. Czeszak, M. Crepin, J. Lemoine, B. Boilly, X. Le Bourhis, J. P. Peyrat, and H. Hondermarck (2001). Proteomic detection of changes in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells. Exp. Cell Res. 262:59-68.
25. M. J. O'Hare (1991). Breast cancer. In J. R. W. Masters (ed.). Human Cancer in Primary Culture, Kluwer Academic, Dordrecht, pp. 271-286.
26. J. D. Wulfkuhle, D. C. Sgroi, H. Krutzsch, K. McLean, K. McGarvey, M. Knowlton, S. Chen, H. Shu, A. Sahin, R. Kurek, D. Wallwiener, M. J. Merino, E. F. Petricoin III, Y. Zhao, and P.S. Steeg (2002) Proteomics of human breast ductal carcinoma in situ. Cancer Res. 62:6740-6749.
27. C. Clarke, J. Titley, S. Davies, and M. J. O'Hare (1994). An immunomagnetic separation method using superparamagnetic (MACS) beads for large-scale purification of human mammary luminal and myoepithelial cells. Epithelial Cell Biol. 3:38-46.
28. M. J. Page, B. Amess, R. R. Townsend, R. Parekh, A. Herath, L. Brusten, M. J. Zvelebil, R. C. Stein, M. D. Waterfield, S. C. Davies, and M. J. O'Hare (1999). Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. Proc. Natl. Acad. Sci. U.S.A. 96:12589-12594.
29. A. C. Stamps, S. C. Davies, J. Burman, and M. J. O'Hare (1994). Analysis of proviral integration in human mammary epithelial cell lines immortalized by retroviral infection with a temperature-sensitive SV40 T-antigen construct. Int. J. Cancer 57:865-874.
30. R. A. Harris, T. J. Eichholtz, I. D. Hiles, M. J. Page, and M. J. O'Hare (1999). New model of ErbB-2 over-expression in human mammary luminal epithelial cells. Int. J. Cancer 80:477-484.